| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |